1-Reinhart K, Bauer M, Riedemann NC and Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012;25:609-34.
2-Lacroix J and Cotting J. Severity of illness and organ dysfunction scoring in children .Pediatr Crit Care Med 2005;6:126-34.
3-Ntusi N, Aubin L, Oliver S, Whitclaw A and Mendelson M. Guideline for the optimal use of blood cultures. SAMJ 2010;100:839-42.
4-Oncel MY, Dilmen U, Erdeve O, Ozdemir R, Calisici E, Yurttutan S, Canpolat FE, Oquz SS and Uras N. Proadrenomedullin as a prognostic marker in neonatal sepsis. .Pediatr Res 2012; 72:507-12.
5-Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullinN-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001;22:1693–711.
6-Martinez A, Pio R, Zipfel PF and Cuttitta F. Mapping of the adrenomedullin-binding domains in human complement factor H. Hypertens Res 2003;26:55-9.
7-Struck J, Tao C, Morgenthaler NG and Bergmann A. Identification of adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004;25:1369-72.
8-Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL and Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296-327.
9- Singhal D, Kumar N, Puliyel JM, Singh SK and Srinivas V. Prediction of mortality by application of PRISM score in intensive care unit. Indian Pediatr 2001;38:714-9
Available at: https://www.ncbi.nlm.nih.gov/pubmed/11463958
10- Wernovsky G, Wypij D, Jonas RA, Mayer JEJr, Hanley FL and Hickey PR . Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-35.
11-Bolton S and Bon C. Pharmaceutical statistics: Practical and Clinical Applications, 5th ed. Broken Sound Parkway, NW. Taylor and Franciṣ. 2009.
https://doi.org/10.3109/9781420074239
12-Monneret G. Immunology programs must include sepsis. Science 2010;328:1106-16.
13-Arabi Y, Al Shirawi N, Memish Z, Venkatesh S and Al-Shimemeri A. Assessment of six mortality prediction models in patients admitted with severe sepsis and septic shock to the intensive care unit: a prospective cohort study. Crit Care 2003;7:116-122.
Available at: https://www.ncbi.nlm.nih.gov/pubmed/12974979
14-Fried E, Weissman C and Sprung C. Postoperative sepsis. Curr Opin Crit Care 2011;17:396-401.
15-Christ-Crain M and Opal SM. Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 2010;14:203-13.
16-Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A and Müller B. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care 2006;10: 96.
17-Jordan I, Corniero P, Balaguer M and Ortiz J. Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children. Biomark Med 2014;8:1065-72.
18-Knoferl MW, Diodato MD, Angele MK, Ayala A, Cioffi WG, Bland KI and Chaudry IH. Do female sex steroids adversely or beneficially affect the depressed immuneresponses in males after trauma-hemorrhage? Arch Surg 2000;135:425-33.
19-Becker KL, Nylen ES, White JC, Müller B and Snider RHJr. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J. Clin Endocrinol Metab.2004;89:1512–25.
20-Linscheid P, Seboek D, Zulewski H, Keller U and Müller B. Autocrine/ paracrine role of inflammation-mediated calcitonin gene related peptide and adrenomedullin expression in human adipose tissue.Endocrinology2005;146:2699-708.
21-Guignant C, Voirin N, Venet F, Malcus C, Bohé J, Lepape A and Monneret G . Assessment of pro-vasopressin and pro-drenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 2009;35:1859–67.
22-Hagag A, Elmahdy HS and Ezzat AA. Prognostic value of plasma Pro-Adrenomdullin and anti-thrombin levels in neonatal sepsis. Indian Pediatrics2011;48:471-3.
23-Wang R and Kang F. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin. Chin J Traumatol2010;13:152-7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/20515592